Kuala Lumpur (VNA) - The MalaysianMinistry of Health on January 26 signed term sheet agreements with two vaccinesuppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd, forthe procurement of 18.4 million doses of COVID-19 vaccine.
The ministry said in a statement that PLS willsupply 12 million doses of COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell)Inactivated produced by Sinovac Life Science Co. Ltd, which will be distributedin stages beginning April.
Duopharma will supply 6.4 million doses of Sputnik Vvaccine, produced by the Gamaleya Research Institute of Epidemiology andMicrobiology in Russia. The vaccine is expected to be distributed in stages byend-March 2021, it said.
The ministry said for the COVID-19 CORONAVACvaccine, SARS-COV-2 Vaccine (Vero Cell) Inactivated, each recipient will begiven two shots 14 days apart.
With the 12 million doses, it expects theimmunisation programme to cover 3.2 million people or 18.75 per cent of theMalaysian population, aged 18 years and above.
As for the Sputnik V vaccine, each recipient willreceive two shots with 21 days interval between the first and second dose, thestatement said, adding the two companies will start supplying the vaccinesafter obtaining approval from the National Pharmaceutical Regulatory Divisionand the Drug Control Authority./.
The ministry said in a statement that PLS willsupply 12 million doses of COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell)Inactivated produced by Sinovac Life Science Co. Ltd, which will be distributedin stages beginning April.
Duopharma will supply 6.4 million doses of Sputnik Vvaccine, produced by the Gamaleya Research Institute of Epidemiology andMicrobiology in Russia. The vaccine is expected to be distributed in stages byend-March 2021, it said.
The ministry said for the COVID-19 CORONAVACvaccine, SARS-COV-2 Vaccine (Vero Cell) Inactivated, each recipient will begiven two shots 14 days apart.
With the 12 million doses, it expects theimmunisation programme to cover 3.2 million people or 18.75 per cent of theMalaysian population, aged 18 years and above.
As for the Sputnik V vaccine, each recipient willreceive two shots with 21 days interval between the first and second dose, thestatement said, adding the two companies will start supplying the vaccinesafter obtaining approval from the National Pharmaceutical Regulatory Divisionand the Drug Control Authority./.
VNA